HeartFlow inks $215m Series F

Bain Capital Life Sciences led the round.

6 April 2023•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Briefs